Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Results 61 - 78 of 78 : « Previous 1 2 3 4

Recs

0
Member Avatar optionsdiablo (28.88) Submitted: 1/25/2007 12:37:37 PM : Outperform Start Price: $16.58 RDY Score: +84.52

Tremendous growth stock

Recs

0
Member Avatar OzSmall (93.56) Submitted: 1/20/2007 8:25:08 AM : Outperform Start Price: $17.81 RDY Score: +71.89

drugs are where its at

Recs

0
Member Avatar tungala (< 20) Submitted: 1/16/2007 2:39:30 PM : Outperform Start Price: $17.41 RDY Score: +75.79

Rapid expansion through acquisitions, more and more US FDA approvals and vast range of molecules under research at different levels.

Recs

0
Member Avatar surinder10 (< 20) Submitted: 12/31/2006 3:32:57 PM : Underperform Start Price: $17.49 RDY Score: -74.49

A GREAT LOW PRICE DRUG PRODUCER.

MEDICINES IN INDIA ARE UNBELIEVABLY CHEAP, THIS STOCK WILL NOT MISS TO GROWWW.

Recs

0
Member Avatar kunitzmi (90.68) Submitted: 12/29/2006 9:00:35 PM : Outperform Start Price: $17.49 RDY Score: +74.49

Market leader in Indian pharmaceuticals. Making good headway in the US market. Solid research and studies management.

Recs

0
Member Avatar dpmf (94.95) Submitted: 12/29/2006 5:46:52 AM : Outperform Start Price: $17.53 RDY Score: +73.87

Low cost generic drugs are already a huge market and it will get bigger. Huge revenue growth rates. Plenty of room for growth in this area.

Recs

0
Member Avatar quail0275 (< 20) Submitted: 12/16/2006 3:13:08 PM : Outperform Start Price: $17.25 RDY Score: +77.10

Democrats in power = cheaper drugs

Recs

0
Member Avatar chulbula1941 (52.95) Submitted: 12/7/2006 6:13:07 PM : Outperform Start Price: $16.43 RDY Score: +84.79

Great Drug Company

Recs

0
Member Avatar callthecash (< 20) Submitted: 12/7/2006 4:29:47 PM : Outperform Start Price: $16.43 RDY Score: +84.79

Merck is outsourcing some of it generic drugs to Reddy. Relationship made in heaven.

Recs

0
Member Avatar indysammy (< 20) Submitted: 11/20/2006 10:07:03 AM : Outperform Start Price: $15.30 RDY Score: +97.79

Indian pharma is growing & RDY is in lead...

Recs

0
Member Avatar atxrrl (88.60) Submitted: 11/17/2006 5:46:06 PM : Outperform Start Price: $15.25 RDY Score: +98.41

Small and good management. They have already a broad product line. will be volatile!

Recs

0
Member Avatar usnavycdr (54.37) Submitted: 11/16/2006 7:53:04 PM : Outperform Start Price: $15.28 RDY Score: +97.82

Invest in India early for big gains.

Recs

0
Member Avatar simon12345spear (< 20) Submitted: 11/10/2006 6:24:41 AM : Outperform Start Price: $16.79 RDY Score: +78.77

i anticipate results continuing to impress. Analysts expectations mean nothing because of the acquisitions so management feeds the PR machine with information they later impress with. A bigger and bigger story easy to manipulate and as they get better at coopying and get better relationships with the bigger players - snowball spring to mind.

Recs

0
Member Avatar fool75243 (< 20) Submitted: 10/6/2006 12:16:45 PM : Outperform Start Price: $14.78 RDY Score: +100.21

India will be a force in the pharma field in the future and there are indications that it already is (i.e. generics). This company is well positioned to be a frontrunner

Recs

0
Member Avatar cunnin7003 (58.14) Submitted: 9/30/2006 12:12:39 AM : Outperform Start Price: $15.20 RDY Score: +94.12

I want to explore this company further before investing in it, but at first glance I like it.

Recs

0
Member Avatar nirbhayk (68.54) Submitted: 9/13/2006 3:48:20 PM : Outperform Start Price: $15.27 RDY Score: +91.08

huge upside...

Recs

0
Member Avatar computersd2000 (< 20) Submitted: 8/28/2006 5:53:37 PM : Outperform Start Price: $15.03 RDY Score: +93.35

RDY or Dr. Reddy's Laboratories is an Indian company that is a generic drug and API (active pharmaceutical ingredient )manufacturer. In 2005 and 2006, a lot of the patents owned by large US pharmaceuticals have come off the patent protection. This opens the doors for generic drug manufacturers to produce similar drugs at much lower prices. This is an emerging market company that is listed in NYSE - as part of our continuing analyis of emerging market segment, we will look at this company in more detail.

Recs

0
Member Avatar bvbuyhighselllow (67.64) Submitted: 8/26/2006 5:18:35 AM : Outperform Start Price: $14.95 RDY Score: +93.85

undervalued at this price

Results 61 - 78 of 78 : « Previous 1 2 3 4

Featured Broker Partners


Advertisement